Structure-based design of novel conformationally restricted HIV protease inhibitors

ACS Symposium Series

Volumn 719, Issue , 1999, Pages 185-197

  Rao, B G ^a   Baker, C T ^a   Court, J T ^a   Deininger, D D ^a   Griffith, J P ^a   Kim, E E ^a   Kim, J L ^a   Li, B ^a   Pazhanisamy, S ^a   Salituro, F G ^a   Schairer, W C ^a   Tung, R D ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040196036     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-1999-0719.ch012     Document Type: Article

References (8)

1. Chrusciel, R. A.; Romines, K. R. Exp. Opin. Ther. Patents, 1997, 7, 111.
2. Painter, G. R.; Ching, S.; Reynolds D.; St. Clair M.; Sadler B. M.; Elkins M.; Blum, R.; Dornsife, R; Livingston, D. J; Parteledis, J. A.; Pazhanisamy, S; Tung, R. D., Tisdale, M. Drugs of the Future, 1996, 21, 347.
3. Kim, E. .E.; Baker; C. T.; Dwyer, M. D.; Murcko, M. A.; Rao, B. G.; Tung, R. D.; Navia, M.A. J. Am. Chem. Soc., 1995, 117, 1181.
4. Navia, M. A.; Sato, V. L.; Tung, R.D. International Antiviral News, 1995, 3, 143.
5. Partaledis, J. A.; Yamaguchi, K.; Tisdale, M; Blair, E. E.; Falcione, C.; Maschera, B.; Myers, R. E.; Pazhanisamy, S.; Futer, O.; Cullinan, A. B.; Stuver, C.; Byrn, R. A.; Livingston, D. J. J. Virol. 1995, 69, 5228.
6. Pazhanisamy, S.; Stuver, C. M.; Cullinan, A. B.; Margolin, N.; Rao, B. G.; Livingston, D. J. J. Biol. Chem., 1996, 271, 17979.
7. Rao, B. G.; Dwyer, M. D.; Deininger, D. D.; Tung, R. D.; Navia, M. A.; Kim, E. E. Antiviral Therapy, 1996, 1(Suppl. 1), 13.
8. Brunger, A. T.; Krukowski, A.; Erickson, J. W. Acta Cryst., 1990, A46, 585.